Rapid Growth of Biliary Stent Systems Market 2021 | Top Key Companies (BD, Allium, Cook, Medtronic, ENDOCOR, ELLA-CS, MITech) | Forecasts till 2025

Global Biliary Stent Systems Market Synopsis:

The report covers a forecast and an analysis of the Biliary Stent Systems Market on a global and regional level. The study provides historical data for 2015, 2016, 2017 and 2018 along with a forecast from 2020 to 2025 based on revenue (USD Million) and volume (Kilotons). The study includes drivers and restraints of the Biliary Stent Systems Market along with the impact they have on the demand over the forecast period.

The major key factors driving the growth of the Global Biliary Stent Systems Market are high prevalence of biliary diseases across the globe, increasing surgical procedures of biliary diseases, rise in usage of substitutes in biliary surgeries. High cost of procedure of biliary stents insertion is also adversely affecting the market growth. Further investigation on how to increase patency period for plastic and metal stents could be the research highlight in coming years.

Available Exclusive Sample Copy of this Report @ https://www.businessindustryreports.com/sample-request/283922 .

On the basis of Regional analysis, North America is expected to account for major share of the Global Biliary Stent Systems Market during the forecast period owing to the developed healthcare infrastructure and rise in population suffering from biliary disorders. Europe is anticipated to be the second largest region of the Global Biliary Stent Systems Market. India and China are the developing countries in APAC.

This report contains a complete product overview and its scope in the market to define the key terms and provide the clients a holistic idea of the market and its tendency. It comprehensively evaluates the Global Biliary Stent Systems Market with different perspectives for the purpose of providing a detailed, informative, and accurate analysis of regional growth, competition, market segmentation, and other important aspects.

Global Key Players:

1 Allium

2 Cook

3 Medtronic

4 BD

5 ENDOCOR

6 Dispomedica

7 ELLA-CS

8 Shanghai INNOVEX Medical Devices

9 Optimed Medical Instruments

10 Medinol

12 Endotech

13 MITech and More………………

Purchase this report online with 90 Pages, List of Tables & Figures and in-depth Table of Contents on “Global Biliary Stent Systems Market Report 2021” @ https://www.businessindustryreports.com/buy-now/283922/single .

Product Type Segmentation

1 Conventional Un-covered Stent

2 Hybrid weaving type Stent

Industry Segmentation

1 Hospitals

2 Clinics

International Medical Industry News:

BD (Becton, Dickinson and Company) (February 17, 2021) - FDA Circulatory System Devices Panel Voted Favorably on Safety, but Does Not Provide a Favorable Recommendation Regarding Lutonix 014 Drug Coated Balloon for Below-the-Knee Procedures - BD (Becton, Dickinson and Company), a leading global medical technology company, today announced that the U.S. Food and Drug Administration’s (FDA) Circulatory System Devices Advisory Panel did not provide a favorable recommendation to the FDA for use of the Lutonix 014 Drug Coated Balloon (DCB) in the treatment of below-the-knee (BTK) arteries in patients with critical limb ischemia (CLI).

The Panel voted 15 to 2 in favor on the issue of safety when used as intended and voted 15 to 2 against on the issue of a reasonable assurance of effectiveness. The third vote was 14 to 3 against whether the benefits outweigh the risks. There was one abstention in all three votes.

The Panel was convened to provide expert input and recommendations to FDA to support the Agency’s review of Lutonix 014 DCB used in the treatment of below-the-knee arteries in patients with CLI, which would be the first and only DCB available for this vulnerable patient population in the United States.

Information presented at today’s panel meeting included six-month primary endpoint data, and safety data out to 36 months from the Lutonix BTK IDE pivotal trial, which is a global, multicenter, prospective, single-blind, randomized, 51-site study that enrolled 462 patients from the United States, Europe, Canada and Japan.

The Lutonix 014 DCB remains under review by FDA for the treatment of patients with CLI who have obstructive de novo or non-stented restenotic lesions in native popliteal, tibial and peroneal arteries up to 320 mm in length and 2.0 to 4.0 mm in diameter.

“While the Panel’s vote on the question of safety was favorable, their votes on effectiveness and risk-benefit focused on study design and the challenges of executing a trial over eight years in this complex patient population,” said Dr. J.D. Meler, Vice President of Medical Affairs for BD's Peripheral Intervention business. “We thank FDA and the Panel for the opportunity to bring these important data to light in this area of unmet need, and thank the clinicians, patients and advocates who shared their personal thoughts and experiences with the Panel.”

Grab Your Report at an Impressive Discount @ https://www.businessindustryreports.com/check-discount/283922 .

Major Points in Table of Contents:

Global Biliary Stent Systems Market Report 2021

1 Biliary Stent Systems Product Definition

2 Global Biliary Stent Systems Market Manufacturer Share and Market Overview

2.1 Global Manufacturer Biliary Stent Systems Shipments

2.2 Global Manufacturer Biliary Stent Systems Business Revenue

2.3 Global Biliary Stent Systems Market Overview

2.4 COVID-19 Impact on Biliary Stent Systems Industry

3 Manufacturer Biliary Stent Systems Business Introduction

3.1 Allium Biliary Stent Systems Business Introduction

3.2 Cook Biliary Stent Systems Business Introduction

3.3 Medtronic Biliary Stent Systems Business Introduction

3.4 BD Biliary Stent Systems Business Introduction

3.5 ENDOCOR Biliary Stent Systems Business Introduction

3.6 Dispomedica Biliary Stent Systems Business Introduction

About us

BusinessindustryReports.com is a digital database of comprehensive market reports for global industries. As a market research company, we take pride in equipping our clients with insights and data that hold the power to truly make a difference to their business. Our mission is singular and well-defined – we want to help our clients envisage their business environment so that they are able to make informed, strategic, and therefore successful decisions for themselves.

Media Contact

Business Industry Reports

Pune – India

sales@businessindustryreports.com

+19376349940

This release was published on openPR.